The global breast cancer therapeutics market is estimated to grow significantly at a CAGR of 9.0% during the forecast period. The growth of the market is attributed to the increasing prevalence of breast cancer and rising awareness in emerging countries such as India, China, and Malaysia. Furthermore, the introduction of new technology such as imaging technology and 3D mammography is also estimated to have a significant impact on the growth of the market. The global expenditure on breast cancer therapies and medicines is increasing very rapidly which leads to the high rates of diagnosis and treatment of breast cancer. However, the high cost of breast cancer drugs and surgeries across the developed countries are estimated to be the major constraints in the growth of the market. As per the American Cancer Society, breast cancer treatment can cost more than $100,000 in developed countries such as the US.
To Request a Sample of our Report on Global Breast Cancer Therapeutics Market: https://www.omrglobal.com/request-sample/breast-cancer-therapeutics-market
Global breast cancer therapeutics market is segmented on the basis of Therapy. The Therapy segment is further classified into chemotherapy, hormone therapy, targeted therapy, radiation therapy and others (surgery). Among all therapies, chemotherapy market held the largest market share in the global breast cancer therapeutics market. Chemotherapy is most used when cancer in the lymph nodes and irrespective of tumor size or menopausal status. Along with that it is used for the treatment of breast cancer in premenopausal women and referred for those women who diagnosed with early stage breast cancer for hormone receptor negative and HER2 positive cancer. The types of chemotherapy include adjuvant chemotherapy and neoadjuvant chemotherapy. The adjuvant chemotherapy is used to destroy cancer cells that have been spread and not seen by the imaging tests. This method helps in reducing the cancer cells that form a new tumor in the other place of the body. Adjuvant chemotherapy reduces the risk of breast cancer coming back. Neoadjuvant chemotherapy can be used to reduce the size of the tumor, so it can be removed with less widespread surgery. Based on geography the global breast cancer therapeutics market is further categorized into North America, Europe, Asia-Pacific and Rest of the World.
(Get 15% Discount on Buying this Report)
A full Report of Global Breast Cancer Therapeutics Market is Available @ https://www.omrglobal.com/industry-reports/breast-cancer-therapeutics-market
Global Breast Cancer Therapeutics Market Segmentation
By Therapeutics
- Chemotherapy
- Hormone Therapy
- Targeted Therapy
- Others (Radiation Therapy, Surgery)
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Company Profiles
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca PLC
- Astellas Pharma Inc.
- Bayer AG
- Bristol-Myers Squibb Co.
- Celldex Therapeutics, Inc.
- Eisai Co., Ltd.
- Eli Lilly and Co.
- GlaxoSmithKline PLC
- Halozyme, Inc.
- Johnson & Johnson Services Inc.
- Merck & Co., Inc.
- Mylan NV
- MacroGenics, Inc.
- Novartis International AG
- Pfizer Inc.
- F. Hoffmann-La Roche AG
- Sanofi S.A.
- Takeda Pharmaceutical Co. Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
